PHARMA
GSK Announces Major New Commitment To Asia
The new global headquarters for Asia is expected to help GSK build talent and better support patients and consumers across the region.
Thermo Fisher Licenses ToolGen’s Gene Editing IP
Thermo Fisher will utilize ToolGen's technology to develop and market new CRISPR reagent kits.
Green Cross Expands Cell Therapy Business In China
Green Cross has signed an MOU to expand its cell therapy facilities in Guizhou, China.
WuXi To Build Third Cell Therapy Facility
The company's third cell therapy manufacturing facility will focus on chimeric antigen receptor T cells for cancer immunotherapy.
Astellas Receives FDA Approval for Anti-Fungal Drug
Astellas' recently approved anti-fungal drug could be used to treat immunocompromised patients facing life threatening fungal infections.
Eisai & Merck To Test Combination Cancer Drugs
Eisai and Merck have entered a partnership to test combinations of their patented drugs on breast and other cancers.
Eisai Expands Facilities In Suzhou
The expansion of Eisai's manufacturing capabilities at the Suzhou Industrial Park reflects China's growing importance for the Japanese pharmaceutical company.
Cipla Awarded US$189 Million Of Global Fund ARV Tender
Cipla has been selected by the Global Fund to produce anti-retroviral drugs for the next three years.
Eisai’s Thyroid Cancer Drug Gets US FDA Approval
A Phase III trial has shown that the drug Lenvima significantly improves the progression-free survival of thyroid cancer patients.
